Why the study?
Does intravenous verapamil cause adverse effects in infants with supraventricular tachycardia?
Population
2 infants with supraventricular tachycardia
Design
Case_series
Authors
Loading...
Caution advised with IV verapamil in infants with SVT; leaves open need for controlled safety data.
Does intravenous verapamil cause adverse effects in infants with supraventricular tachycardia?
Intravenous verapamil should be avoided in neonates and young infants with supraventricular tachycardia due to the risk of life-threatening bradycardia and hypotension.
Dorothy J. Radford (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: